Reuters UK Business

Roche pauses shipments of Elevidys gene therapy outside US

(Reuters) -Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside the U.S., echoing a similar decision by U.S. partner Sarepta Therapeutics. The Swiss drugmaker said the pause, effective Tuesday, applies to new orders of Elevidys in countries outside the U.S. that reference the Food …

Roche pauses shipments of Elevidys gene therapy outside US Read More »

Renault second-quarter sales volumes flat on drop in demand for vans

PARIS (Reuters) -Renault reported zero growth in second-quarter sales volume on Wednesday, after a plunge in demand for vans in Europe offset growth in passenger cars. The French automaker, which had warned last week of weaker than expected June sales volumes, said its second-quarter sales were down 0.1%, despite a raft of new vehicle launches. …

Renault second-quarter sales volumes flat on drop in demand for vans Read More »

Germany’s offshore wind roll-out stalls in H1, lobbies want auction design reforms

FRANKFURT (Reuters) -Germany left installed offshore power wind capacity unchanged in the first half of 2025 and industry groups on Wednesday urged the government to introduce improved auction measures this year to ensure more turbine additions. As of June 30, 2025, the country had 9.2 gigawatts (GW) of installed offshore capacity, unchanged from Dec. 31, …

Germany’s offshore wind roll-out stalls in H1, lobbies want auction design reforms Read More »

Lonza tops core profit forecast driven by main drug manufacturing business

(Corrects typographical error in headline with no changes to text) By Isabel Demetz and Bernadette Hogg (Reuters) -Switzerland’s Lonza posted 23% growth in its half-year core profit on Wednesday, beating market expectations, driven by a strong performance in its contract drug manufacturing (CDMO) business and contributions from its Vacaville site in the U.S. Lonza, which …

Lonza tops core profit forecast driven by main drug manufacturing business Read More »

Recruiter Randstad flags signs of stabilization as uncertainty becomes ‘new norm’

By Olivier Cherfan and Mateusz Rabiega (Reuters) -Randstad signalled improvements in some key markets on Wednesday, with higher demand for outsourcing of recruitment, as staffing firms face a new normal marked by heightened uncertainty. Recruiters including Randstad, Adecco and Hays have voiced concerns about the worsening job market driven by an escalating global trade war …

Recruiter Randstad flags signs of stabilization as uncertainty becomes ‘new norm’ Read More »

CapVest eyes majority stake in German drugmaker Stada, Bloomberg News reports

(Reuters) -London-based buyout firm CapVest Partners is in talks to acquire a majority stake in German drugmaker Stada Arzneimittel, Bloomberg News reported on Tuesday. The deal would value Stada Arzneimittel at about 10 billion euros ($11.75 billion) including debt, the report said, citing unnamed sources. CapVest is in discussions with Stada’s private equity owners, Bain …

CapVest eyes majority stake in German drugmaker Stada, Bloomberg News reports Read More »

EU court cuts Credit Suisse fine for foreign exchange cartel

BRUSSELS (Reuters) -The European Union’s General Court substantially reduced a fine imposed on Credit Suisse to 28.9 million euros ($33.92 million) from 83.2 million euros on Wednesday, over its participation in a foreign exchange trading cartel. The court ruled that Credit Suisse had participated in the cartel, but the European Commission had not correctly determined …

EU court cuts Credit Suisse fine for foreign exchange cartel Read More »

Cost-cutting boosts voucher provider Edenred’s half-year core earnings

(Reuters) -French vouchers and benefit cards provider Edenred reported half-year core earnings above market expectations on Wednesday, citing strong performance in Latin America and a boost from its plan to cut costs. Early on Wednesday, Edenred’s shares traded as much as 2.2% higher before paring gains to rise 0.6% on the day, as analysts cited …

Cost-cutting boosts voucher provider Edenred’s half-year core earnings Read More »

UK watchdog probes Deloitte’s audits of Glencore’s 2013-2020 accounts

(Reuters) -Britain’s accounting watchdog said on Wednesday that it is investigating Deloitte LLP’s audits of commodities trader Glencore and one of its divisions for the financial years ended December 2013 through December 2020. The Financial Reporting Council (FRC) is examining whether Deloitte properly assessed the risk of legal and regulatory breaches during its audits. Glencore …

UK watchdog probes Deloitte’s audits of Glencore’s 2013-2020 accounts Read More »

Wetherspoon’s sales rise as Brits toast summer with sparkling wines and Guinness

By Unnamalai L and Yadarisa Shabong (Reuters) -J D Wetherspoon reported a rise in sales in recent weeks since May as people flocked to pubs for beers and sparkling wines amid hot weather in Britain. The pub group, known for its affordable drinks and pub grub, reported a 5.1% rise in like-for-like sales in the …

Wetherspoon’s sales rise as Brits toast summer with sparkling wines and Guinness Read More »

Close Bitnami banner
Bitnami